NCT02142725View on ClinicalTrials.gov

Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis

PHASE3TerminatedINTERVENTIONAL
Enrollment

468

Participants

Timeline

Start Date

July 21, 2014

Primary Completion Date

November 11, 2016

Study Completion Date

December 16, 2016

Conditions
Ulcerative Colitis
Interventions
DRUG

LT-02

four times per day

DRUG

LT-02

two times per day

DRUG

Placebo

four times per day

Trial Locations (1)

60431

Agaplesion Markus-Krankenhaus, 1st Dept. of Medicine, Frankfurt a.M.

Sponsors
All Listed Sponsors
lead

Dr. Falk Pharma GmbH

INDUSTRY